These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10839758)

  • 1. Antibiotics in the prevention and treatment of coronary heart disease.
    Meier CR
    J Infect Dis; 2000 Jun; 181 Suppl 3():S558-62. PubMed ID: 10839758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics for the secondary prevention of ischemic heart disease: a meta-analysis of randomized controlled trials.
    Wells BJ; Mainous AG; Dickerson LM
    Arch Intern Med; 2004 Oct; 164(19):2156-61. PubMed ID: 15505130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microorganisms and coronary heart disease. Do antibiotics protect against cardiac events?].
    Jahn J; Dalhoff K; Richardt G
    MMW Fortschr Med; 2002 Oct; 144(41):41-2. PubMed ID: 12474361
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial.
    Dunne MW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S572-8. PubMed ID: 10839762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the secondary prevention of coronary heart disease.
    Veverka A; Jolly JL
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):877-89. PubMed ID: 15500433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
    Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is infection a pathogenetic factor in coronary heart disease?].
    Sommerschild HT
    Ugeskr Laeger; 2001 Mar; 163(13):1834-42. PubMed ID: 11293311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary prevention in acute myocardial infarction].
    Ferreira R; Ferreira D; Correia MJ; De Sá ME; De Sousa JV; Sousa JV; Tavares MG
    Acta Med Port; 2001; 14(2):149-69. PubMed ID: 11475986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is infection a pathogenetic factor in coronary heart disease?].
    Sommerschild HT
    Tidsskr Nor Laegeforen; 2000 Nov; 120(28):3396-403. PubMed ID: 11187193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description and status of the azithromycin and coronary events study (ACES).
    Jackson LA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S579-81. PubMed ID: 10839763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics in primary prevention of myocardial infarction among elderly patients with hypertension.
    Brassard P; Bourgault C; Brophy J; Kezouh A; Rainville B; Xhignesse M; Suissa S
    Am Heart J; 2003 May; 145(5):E20. PubMed ID: 12766754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible role of infections in acute myocardial infarction.
    Meier CR
    Biomed Pharmacother; 1999 Oct; 53(9):397-404. PubMed ID: 10554674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections, atherosclerosis, and coronary heart disease.
    Famularo G; Trinchieri V; Santini G; De Simone C
    Ann Ital Med Int; 2000; 15(2):144-55. PubMed ID: 10920505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
    Dahabreh IJ; Economopoulos K
    Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.